Yhlo Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 1,664

Employees

  • Stock Symbol
  • 688575

Stock Symbol

  • Investments
  • 10

  • Share Price
  • $1.43
  • (As of Friday Closing)

Yhlo General Information

Description

Shenzhen YHLO Biotech Co Ltd is engaged in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Its product portfolio includes solutions based on technologies such as chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. Its products are used in diagnostic applications including autoimmunity, reproductive health, infection, liver disease, and respiratory disease testing, and are supplied to healthcare institutions and testing centers.

Contact Information

Website
www.szyhlo.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • No. 65, Baolong 2nd Road
  • Baolong Street, Longgang District
  • Shenzhen, Guangdong 518116
  • China
+86 0755
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • No. 65, Baolong 2nd Road
  • Baolong Street, Longgang District
  • Shenzhen, Guangdong 518116
  • China
+86 0755

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Yhlo Stock Performance

As of 20-Nov-2026, Yhlo’s stock price is $1.43. Its current market cap is $816M with 571M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.43 $1.52 $1.23 - $2.43 $816M 571M 10.8M $0.03

Yhlo Financials Summary

As of 30-Sep-2026, Yhlo has a trailing 12-month revenue of $283M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 938,138 1,218,061 1,278,782 1,839,329
Revenue 283,296 251,779 280,347 290,196
EBITDA 29,605 55,773 78,913 73,931
Net Income 15,446 3,246 42,023 50,180
Total Assets 647,106 612,965 604,799 536,930
Total Debt 131,224 128,048 124,079 78,662
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Yhlo Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Yhlo‘s full profile, request access.

Request a free trial

Yhlo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Yhlo Investments & Acquisitions (10)

Yhlo’s most recent deal was a Later Stage VC with E-Health Now. The deal was made on 02-Mar-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
E-Health Now 02-Mar-2026 Later Stage VC Practice Management (Healthcare)
Longlight 08-Oct-2024 Later Stage VC Discovery Tools (Healthcare)
Shanghai Zhenxi 08-May-2024 Corporate Laboratory Services (Healthcare)
Yahuilong Biotechnology 09-Nov-2022 Merger/Acquisition Diagnostic Equipment
Rayertech 30-Sep-2022 Corporate Therapeutic Devices
You’re viewing 5 of 10 investments and acquisitions. Get the full list »

Yhlo ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

34.98 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,999

Rank

Percentile

Healthcare

Industry

of 665

Rank

Percentile

Medical Devices

Subindustry

of 235

Rank

Percentile

To view Yhlo’s complete esg history, request access »

Yhlo Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Yahuilong Biotechnology Nanjing, China 2001

Yhlo FAQs

  • When was Yhlo founded?

    Yhlo was founded in 2008.

  • Where is Yhlo headquartered?

    Yhlo is headquartered in Shenzhen, China.

  • What is the size of Yhlo?

    Yhlo has 1,664 total employees.

  • What industry is Yhlo in?

    Yhlo’s primary industry is Diagnostic Equipment.

  • Is Yhlo a private or public company?

    Yhlo is a Public company.

  • What is Yhlo’s stock symbol?

    The ticker symbol for Yhlo is 688575.

  • What is the current stock price of Yhlo?

    As of 20-Nov-2026 the stock price of Yhlo is $1.43.

  • What is the current market cap of Yhlo?

    The current market capitalization of Yhlo is $816M.

  • What is Yhlo’s current revenue?

    The trailing twelve month revenue for Yhlo is $283M.

  • What is Yhlo’s annual earnings per share (EPS)?

    Yhlo’s EPS for 12 months was $0.03.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process